Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.

Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.

Eur J Pediatr. 2013 Apr;172(4):513-8. doi: 10.1007/s00431-012-1913-3. Epub 2012 Dec 28.

PMID:
23271494
2.

[Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].

Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.

Przegl Lek. 2006;63 Suppl 3:44-8. Polish.

PMID:
16898486
3.

Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.

Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.

Pediatr Nephrol. 2015 Apr;30(4):687-91. doi: 10.1007/s00467-014-3034-x. Epub 2015 Jan 10.

PMID:
25576066
4.

Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.

Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.

Pediatr Nephrol. 2011 Oct;26(10):1823-8. doi: 10.1007/s00467-011-1886-x. Epub 2011 May 10.

PMID:
21556716
5.

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.

Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.

Pediatr Nephrol. 2007 Jan;22(1):71-6. Epub 2006 Nov 4.

PMID:
17086405
6.

Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.

Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.

Clin Nephrol. 2009 Oct;72(4):268-73.

PMID:
19825332
7.

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.

Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.

Pediatr Nephrol. 2005 Jul;20(7):914-9. Epub 2005 May 13.

PMID:
15891923
8.

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.

Bagga A, Hari P, Moudgil A, Jordan SC.

Am J Kidney Dis. 2003 Dec;42(6):1114-20.

PMID:
14655181
9.

Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.

Gellermann J, Weber L, Pape L, Tönshoff B, Hoyer P, Querfeld U; Gesellschaft für Pädiatrische Nephrologie (GPN).

J Am Soc Nephrol. 2013 Oct;24(10):1689-97. doi: 10.1681/ASN.2012121200. Epub 2013 Jun 27.

10.

Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.

Gellermann J, Ehrich JH, Querfeld U.

Nephrol Dial Transplant. 2012 May;27(5):1970-8. doi: 10.1093/ndt/gfr572. Epub 2011 Oct 4.

PMID:
21976740
11.

Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome.

Basu B, Mahapatra TK, Mondal N.

Pediatrics. 2015 Jul;136(1):e132-9. doi: 10.1542/peds.2015-0486.

12.

Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.

Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.

Nephrology (Carlton). 2016 Jan;21(1):21-7. doi: 10.1111/nep.12537.

PMID:
26697959
13.

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.

Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ.

Pediatr Nephrol. 2008 Nov;23(11):2013-20. doi: 10.1007/s00467-008-0899-6. Epub 2008 Jul 12.

PMID:
18622632
14.

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.

Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.

Pediatr Nephrol. 2005 Apr;20(4):482-5. Epub 2005 Feb 18.

PMID:
15719253
15.

Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.

Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.

Pediatr Int. 2015;57(1):85-91. doi: 10.1111/ped.12498. Epub 2014 Nov 25.

PMID:
25225083
16.

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.

Pediatr Nephrol. 2010 Mar;25(3):539-44. doi: 10.1007/s00467-009-1377-5. Epub 2010 Jan 5.

PMID:
20049616
17.

New treatment strategies in idiopathic nephrotic syndrome.

Ulinski T, Aoun B.

Minerva Pediatr. 2012 Apr;64(2):135-43. Review.

PMID:
22495188
18.

Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.

Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.

Pediatr Nephrol. 2007 Apr;22(4):600-2. Epub 2007 Jan 18.

PMID:
17235550
19.
20.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960

Supplemental Content

Support Center